ATE421998T1 - Ermittlung des repertoires von b-lymphozyten populationen - Google Patents

Ermittlung des repertoires von b-lymphozyten populationen

Info

Publication number
ATE421998T1
ATE421998T1 AT03293159T AT03293159T ATE421998T1 AT E421998 T1 ATE421998 T1 AT E421998T1 AT 03293159 T AT03293159 T AT 03293159T AT 03293159 T AT03293159 T AT 03293159T AT E421998 T1 ATE421998 T1 AT E421998T1
Authority
AT
Austria
Prior art keywords
heavy chain
repertoire
given type
provides
determination
Prior art date
Application number
AT03293159T
Other languages
English (en)
Inventor
Annick Lim
Brigitte Lemercier
Philippe Kourilsky
Francois Huetz
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE421998T1 publication Critical patent/ATE421998T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03293159T 2003-12-15 2003-12-15 Ermittlung des repertoires von b-lymphozyten populationen ATE421998T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03293159A EP1544308B1 (de) 2003-12-15 2003-12-15 Ermittlung des Repertoires von B-Lymphozyten Populationen

Publications (1)

Publication Number Publication Date
ATE421998T1 true ATE421998T1 (de) 2009-02-15

Family

ID=34486471

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03293159T ATE421998T1 (de) 2003-12-15 2003-12-15 Ermittlung des repertoires von b-lymphozyten populationen

Country Status (3)

Country Link
EP (1) EP1544308B1 (de)
AT (1) ATE421998T1 (de)
DE (1) DE60326052D1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009137255A2 (en) 2008-04-16 2009-11-12 Hudsonalpha Institute For Biotechnology Method for evaluating and comparing immunorepertoires
EP2364368B1 (de) 2008-11-07 2014-01-15 Sequenta, Inc. Verfahren zur überwachung von krankheitszuständen mittels sequenzanalyse
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US9394567B2 (en) 2008-11-07 2016-07-19 Adaptive Biotechnologies Corporation Detection and quantification of sample contamination in immune repertoire analysis
US8691510B2 (en) 2008-11-07 2014-04-08 Sequenta, Inc. Sequence analysis of complex amplicons
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
DK3059337T3 (da) 2009-01-15 2019-07-22 Adaptive Biotechnologies Corp Adaptive immunity profiling og metoder til frembringelse af monoklonale antibodier
RU2014144463A (ru) 2009-06-25 2015-06-20 Фред Хатчинсон Кансэр Рисёч Сентер Способ измерения адаптивного иммунитета
US9043160B1 (en) 2009-11-09 2015-05-26 Sequenta, Inc. Method of determining clonotypes and clonotype profiles
WO2011139372A1 (en) 2010-05-06 2011-11-10 Sequenta, Inc. Sequence analysis of complex amplicons
WO2011140433A2 (en) 2010-05-07 2011-11-10 The Board Of Trustees Of The Leland Stanford Junior University Measurement and comparison of immune diversity by high-throughput sequencing
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
US9279159B2 (en) 2011-10-21 2016-03-08 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
EP3388535B1 (de) 2011-12-09 2021-03-24 Adaptive Biotechnologies Corporation Diagnose von lymphoid-malignomen und nachweis von minimaler resterkrankung
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
DK2823060T3 (en) 2012-03-05 2018-05-28 Adaptive Biotechnologies Corp Determination of associated immune receptor chains from frequency-matched subunits
EP3091089B1 (de) 2012-05-08 2019-01-23 Adaptive Biotechnologies Corporation Verfahren zum vermessen und kalibrieren eines amplifikationsbias in multiplexierten pcr-reaktionen
US20160002731A1 (en) 2012-10-01 2016-01-07 Adaptive Biotechnologies Corporation Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
US10150996B2 (en) 2012-10-19 2018-12-11 Adaptive Biotechnologies Corp. Quantification of adaptive immune cell genomes in a complex mixture of cells
US9909180B2 (en) 2013-02-04 2018-03-06 The Board Of Trustees Of The Leland Stanford Junior University Measurement and comparison of immune diversity by high-throughput sequencing
JP6513035B2 (ja) 2013-02-22 2019-05-15 アダプティヴ バイオテクノロジーズ コーポレーション 希少クロノタイプおよびその用途
EP3611262B1 (de) 2013-03-15 2020-11-11 Lineage Biosciences, Inc. Verfahren zur sequenzierung des immunrepertoirs
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
WO2015134787A2 (en) 2014-03-05 2015-09-11 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
US11390921B2 (en) 2014-04-01 2022-07-19 Adaptive Biotechnologies Corporation Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
CA2966201A1 (en) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
EP3224384A4 (de) 2014-11-25 2018-04-18 Adaptive Biotechnologies Corp. Charakterisierung von adaptiver immunreaktion auf impfungen oder infektionen unter verwendung von immunrepertoiresequenzierung
US11047008B2 (en) 2015-02-24 2021-06-29 Adaptive Biotechnologies Corporation Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
WO2016161273A1 (en) 2015-04-01 2016-10-06 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
GB201612242D0 (en) * 2016-07-14 2016-08-31 Genome Res Ltd And Cambridge Entpr Ltd Novel kit
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
US10822662B2 (en) 2017-03-06 2020-11-03 Karkinos Precision Oncology LLC Diagnostic methods for identifying T-cell lymphoma and leukemia by high-throughput TCR-β sequencing
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
EP3908678A1 (de) 2019-01-10 2021-11-17 Iovance Biotherapeutics, Inc. System und verfahren zur überwachung der klonalität und persistenz von adoptiven zelltherapien
EP4673167A1 (de) 2023-02-27 2026-01-07 Adaptive Biotechnologies Corp. Therapeutische t-zell-rezeptoren zum targeting von kras g12d

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84285A (en) * 1986-10-27 1993-03-15 Int Genetic Engineering Chimeric antibody with specificity to human tumor antigen
IT1244983B (it) * 1991-04-29 1994-09-13 Raggio Italgene Spa Procedimento per rivelare sequenze di acidi nucleici e kit per la sua utilizzazione.
WO1999015696A1 (en) * 1997-09-19 1999-04-01 Medelys Laboratories Inc. Method and kit for early diagnosis of autoimmunity and lymphoma in central nervous system
GB0008419D0 (en) * 2000-04-05 2000-05-24 Bioinvent Int Ab A method for invitro molecular evolution of antibody function
CN1273191C (zh) * 2000-08-11 2006-09-06 法弗里尔公司 用于改变b细胞介导病理的方法和组合物

Also Published As

Publication number Publication date
DE60326052D1 (de) 2009-03-19
EP1544308A1 (de) 2005-06-22
EP1544308B1 (de) 2009-01-28

Similar Documents

Publication Publication Date Title
DE60326052D1 (de) Ermittlung des Repertoires von B-Lymphozyten Populationen
ES2547463T3 (es) Moléculas de unión a ILT3 y usos de las mismas
NO20171697A1 (no) IL-17 Antagonistiske antistoffer
CY1112563T1 (el) Διαταξη και μεθοδος για τον ταυτοχρονο προσδιορισμο των αντιγονων των ομαδων του αιματος
KR950700414A (ko) 사람 인터루킨-4에 대한 사람화 모노클로날 항체의 클로닝 및 발현(Cloning and expression of humanized monoclonal antibodies against human interleukin-4)
AU2003213687A1 (en) Human antibodies specific to kdr and uses thereof
ITRM20030601A1 (it) Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti.
CY1114851T1 (el) Il-1βητα δεσμευτικα αντισωματα και θραυσματα αυτων
AR106199A1 (es) Moléculas de unión a antígeno biespecíficas activadoras de células t
CO5690537A2 (es) Formas solidas de anticuerpos anti-egfr
UY29573A1 (es) Anticuerpos dirigidos contra cd20 y sus usos
IS7253A (is) Mótefni gegn CD40
CY1117302T1 (el) Αντισωματα αντι-mif
NO20061070L (no) Antistoffer mot parathyoidhormon (PTH) og anvendelser derav
ATE476994T1 (de) Antikörper gegen gpnmb und ihre verwendungen
ATE492563T1 (de) Vollständige humane monoklonale antikörper gegen il-13
EP1961826A3 (de) Verfahren zur direkten Sequenzierung von Nukleinsäuren
UY29288A1 (es) Anticuerpos dirigidos contra angiopoyetina-2 y usos de los mismos
DE50002062D1 (de) Testkit und verfahren zum quantitativen nachweis von gentechnisch veränderter dns in lebensmitteln mittels fluoreszenzgekoppelter pcr
ATE441715T1 (de) Streptococcus pyogenes antigene
ATE487142T1 (de) Proteinnachweisreagentien und -verfahren mit farbstoffen und dextrinen
MX2022000988A (es) Proteinas de union a antigeno anti-il13.
EA200600539A1 (ru) Способ определения воздействия многокомпонентной смеси естественных продуктов на биологический профиль заболевания в пределах группы живых систем и разработка и контроль качества лекарственных препаратов на основе естественных продуктов
BRPI0414365A (pt) composições, reagentes e kits para, e métodos de diagnosticar, monitorar e tratar obesidade e/ou diabetes
WO2024138141A3 (en) Antibodies against metapneumovirus fusion (f) protein and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties